Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer
PaperCitations, authors & open-access status
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 50 citations, 2017 year and hybrid oa status.
50
Citations
2017
Year
hybrid
OA Status